Interestingly, the expression of MMP9 of validated genes was prominently up-regulated in subgroups CRPS I (1.9±0.26 times and p = 0.045) and CRPS II patients (6.4±2.47 times and p = 3.4×10−7) (Fig. 4). Here, MMP9 is linked to complex regional pain syndrome type 1.